| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |